Astera Labs (NASDAQ:ALAB) Shares Gap Up – Should You Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $311.99, but opened at $334.49. Astera Labs shares last traded at $331.49, with a volume of 1,007,863 shares traded.

Astera Labs News Roundup

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Northland Securities substantially raised its earnings forecasts. The firm lifted its Q3 2026 EPS estimate to $0.83 from $0.47 and its FY2026 estimate to $2.75 from $1.82. It also increased its FY2027 forecast to $5.43 from $2.26, with quarterly 2027 estimates ranging from $1.13 to $1.55 per share. The revisions signal expectations for stronger AI-connectivity demand and rapid profit growth, although Northland retained a “Market Perform” rating. Northland Securities earnings estimates
• Positive Sentiment: AMD’s planned Helios AI systems ramp could benefit Astera Labs. Analysts identify ALAB as an ecosystem partner that may gain from AMD’s rack-scale AI deployments, potentially increasing demand for the company’s connectivity products. AMD’s Helios Launch Could Create Winners Beyond AMD Stock
• Positive Sentiment: Recent operating momentum supports the bullish forecasts. Astera Labs previously reported quarterly revenue growth of 104.5% year over year, revenue above expectations, and EPS that exceeded consensus estimates.
• Neutral Sentiment: Articles comparing Astera Labs with ASE Technology and the broader computer-and-technology sector provide performance context but do not identify a new company-specific catalyst. Are Computer and Technology Stocks Lagging ASE Technology
• Negative Sentiment: Director Stefan A. Dyckerhoff sold approximately $3.9 million of ALAB shares, reducing his holdings. The transactions were executed under a pre-arranged Rule 10b5-1 plan, which lessens their significance but may still concern investors given the stock’s elevated valuation.

Analyst Ratings Changes

Several research firms recently commented on ALAB. Morgan Stanley increased their price objective on Astera Labs to $335.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target on the stock. TD Cowen lowered their price target on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research report on Wednesday, August 5th. Susquehanna increased their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. Finally, Royal Bank Of Canada raised their target price on shares of Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Thirteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat, Astera Labs currently has a consensus rating of “Moderate Buy” and an average price target of $325.25.

Astera Labs Price Performance

The stock has a market cap of $57.68 billion, a PE ratio of 164.59 and a beta of 3.84. The stock’s fifty day moving average is $359.51 and its 200-day moving average is $237.55.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 14,076 shares of Astera Labs stock in a transaction on Monday, May 18th. The stock was sold at an average price of $231.78, for a total value of $3,262,535.28. Following the sale, the general counsel owned 104,139 shares in the company, valued at $24,137,337.42. The trade was a 11.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares in the company, valued at approximately $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,256,894 shares of company stock valued at $362,763,135 in the last ninety days. 10.40% of the stock is currently owned by corporate insiders.

Institutional Trading of Astera Labs

A number of hedge funds and other institutional investors have recently modified their holdings of ALAB. Vanguard Group Inc. lifted its position in Astera Labs by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after buying an additional 84,365 shares during the last quarter. BlackRock Inc. purchased a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $6,609,581,000. Atreides Management LP lifted its holdings in shares of Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after acquiring an additional 1,754,593 shares during the last quarter. State Street Corp boosted its position in shares of Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after purchasing an additional 760,358 shares during the period. Finally, Geode Capital Management LLC boosted its position in shares of Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after purchasing an additional 104,935 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.